阅读说明：本技术 Eb-1020的晶型及其制备方法和用途 (Crystal form of EB-1020 and preparation method and application thereof ) 是由 陈敏华 张炎锋 翟晓婷 张晓宇 于 2018-10-11 设计创作，主要内容包括：本发明涉及化合物(I)的晶型及其制备方法,含有该晶型的药物组合物,以及该晶型在制备5-羟色胺、去甲肾上腺素和多巴胺三重再摄取抑制剂和/或治疗神经系统障碍药物制剂中的用途。本发明提供的化合物(I)的晶型比现有技术具有一种或多种改进的特性,对未来该药物的优化和开发具有重要价值。<Image he="452" wi="700" file="DDA0002504400700000011.GIF" imgContent="drawing" imgFormat="GIF" orientation="portrait" inline="no"></Image>(The invention relates to a crystal form of a compound (I), a preparation method thereof, a pharmaceutical composition containing the crystal form, and application of the crystal form in preparing a 5-hydroxytryptamine, norepinephrine and dopamine triple reuptake inhibitor and/or a pharmaceutical preparation for treating nervous system disorders. The crystal form of the compound (I) provided by the invention has one or more improved properties compared with the prior art, and has important value for the optimization and development of the medicine in the future.)